OGN Organon & Co.
OGN Organon & Co.
Healthcare · Drug Manufacturers - General
Desk view
Market read
Scan convergence 1 scan as of 2026-10-23 1 bull converging
POC $13.32 · VWAP $10.13 · +35.8% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
OGN Price Structure
Loading timeframes…
Peers
Every watchlist OGN belongs to, members best 30-day change first — OGN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported the quarter ending 2026-06-30: revenue $1.56B, diluted EPS $0.40, net income $108M (SEC filing). Across the print the stock moved +0.1% (close before → first close after).
full note →Against street estimates
How OGN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about OGN from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 6 days ago · Oct 17
- Organon Reports Q1 2026 Results Amid Sun Pharma Merger | OGN News & Analysis
- Rockford Register Star: Local News, Politics & Sports in Rockford, IL - Organon & Co. Common Stock (NYSE:OGN) Stock Quote
- Organon posts Q2 2026 results amid Sun Pharma deal | OGN Quarterly Report (10-Q)
- Organon Reports Results for the First Quarter Ended March 31, 2026
- Sun Pharma signs Definitive Agreement to Acquire Organon
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
OGN research tape
47 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.